IT1293583B1 - Uso dell'acido gammaidrossibutirrico per il trattamento delle sindromi demenziali - Google Patents

Uso dell'acido gammaidrossibutirrico per il trattamento delle sindromi demenziali

Info

Publication number
IT1293583B1
IT1293583B1 IT97MI001613A ITMI971613A IT1293583B1 IT 1293583 B1 IT1293583 B1 IT 1293583B1 IT 97MI001613 A IT97MI001613 A IT 97MI001613A IT MI971613 A ITMI971613 A IT MI971613A IT 1293583 B1 IT1293583 B1 IT 1293583B1
Authority
IT
Italy
Prior art keywords
demential
treating
syndromes
administration
gammahydroxybutyric
Prior art date
Application number
IT97MI001613A
Other languages
English (en)
Italian (it)
Inventor
Franco Beghe
Carlo Bertoni-Freddari
Patrizia Fattoretti
Maria Teresa Carpanini
Ugo Caselli
Roberta Paoloni
Original Assignee
Ct Lab Farm Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ct Lab Farm Srl filed Critical Ct Lab Farm Srl
Priority to IT97MI001613A priority Critical patent/IT1293583B1/it
Publication of ITMI971613A0 publication Critical patent/ITMI971613A0/it
Priority to CA 2217902 priority patent/CA2217902A1/en
Publication of ITMI971613A1 publication Critical patent/ITMI971613A1/it
Application granted granted Critical
Publication of IT1293583B1 publication Critical patent/IT1293583B1/it

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IT97MI001613A 1997-07-07 1997-07-07 Uso dell'acido gammaidrossibutirrico per il trattamento delle sindromi demenziali IT1293583B1 (it)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IT97MI001613A IT1293583B1 (it) 1997-07-07 1997-07-07 Uso dell'acido gammaidrossibutirrico per il trattamento delle sindromi demenziali
CA 2217902 CA2217902A1 (en) 1997-07-07 1997-10-08 Use of gammahydroxybutyrric acid for the treatment of demential syndromes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT97MI001613A IT1293583B1 (it) 1997-07-07 1997-07-07 Uso dell'acido gammaidrossibutirrico per il trattamento delle sindromi demenziali

Publications (3)

Publication Number Publication Date
ITMI971613A0 ITMI971613A0 (en, 2012) 1997-07-07
ITMI971613A1 ITMI971613A1 (it) 1999-01-07
IT1293583B1 true IT1293583B1 (it) 1999-03-08

Family

ID=11377515

Family Applications (1)

Application Number Title Priority Date Filing Date
IT97MI001613A IT1293583B1 (it) 1997-07-07 1997-07-07 Uso dell'acido gammaidrossibutirrico per il trattamento delle sindromi demenziali

Country Status (2)

Country Link
CA (1) CA2217902A1 (en, 2012)
IT (1) IT1293583B1 (en, 2012)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013024028A1 (en) * 2011-08-12 2013-02-21 Institut National De La Sante Et De La Recherche Medicale (Inserm) Compounds and compositions for treating proteinopathies
US11602513B1 (en) 2016-07-22 2023-03-14 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US12186296B1 (en) 2016-07-22 2025-01-07 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
UY37341A (es) 2016-07-22 2017-11-30 Flamel Ireland Ltd Formulaciones de gamma-hidroxibutirato de liberación modificada con farmacocinética mejorada
US11504347B1 (en) 2016-07-22 2022-11-22 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11602512B1 (en) 2016-07-22 2023-03-14 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11986451B1 (en) 2016-07-22 2024-05-21 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
WO2020178695A1 (en) 2019-03-01 2020-09-10 Flamel Ireland Limited Gamma-hydroxybutyrate compositions having improved pharmacokinetics in the fed state
US11779557B1 (en) 2022-02-07 2023-10-10 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11583510B1 (en) 2022-02-07 2023-02-21 Flamel Ireland Limited Methods of administering gamma hydroxybutyrate formulations after a high-fat meal

Also Published As

Publication number Publication date
CA2217902A1 (en) 1999-01-07
ITMI971613A0 (en, 2012) 1997-07-07
ITMI971613A1 (it) 1999-01-07

Similar Documents

Publication Publication Date Title
CA2180535A1 (en) A method for treatment of psoriasis, by omeprazole or related compounds
FI955782L (fi) Menetelmä kivun käsittelemiseksi 24-tunnin suun kautta annettavia opioidiformulointeja, joilla saadaan lääkkeen plasmatason nopea alkunousu
ZA977783B (en) Method of inhibiting fibrosis with a somatostatin agonist
GB2303064B (en) Medicament for nasal administration
EP1086702A3 (en) Method for reduction of headache pain
HUP0000558A3 (en) Use of active d vitamin analogues for producing pharmaceutical composition for the treatment of prostatic diseases
EP1555025A3 (en) Use of dehydroepiandrosterone analogs for the treatment of asthma
EP1029540A3 (en) Use of droloxifene for the treatment of cardiovascular diseases
CA2125662A1 (en) Transdermally administered system containing acetylsalicylic acid for thrombosis therapy and cancer prophylaxis
NO994165L (no) Anvendelse av deskarboetoksyloratadin for fremstilling av et medikament for behandling av urininkontinens, reisesyke og svimmelhet
PL342099A1 (en) Therapeutic agents
IT1293583B1 (it) Uso dell'acido gammaidrossibutirrico per il trattamento delle sindromi demenziali
AU3046897A (en) Uridine-comprising therapeutic active agent for treatment of neurodegenerative disorders
SE9703929D0 (sv) Therapeutical use and method
HK43497A (en) Therapeutic use of somatostatin peptides
HK1046089A1 (zh) 褪黑激素的治疗用途
EP0765661A3 (en) Use of docosahexaenoic acid for the manufacture of a medicament for the treatment of glumerulonephritis
EP0689839A3 (en) Use of adenosine triphosphatase inhibitors for the manufacture of a medicament for the treatment of beta-amyloid peptide-associated disorders
PT1019068E (pt) Formulações terapêuticas contendo veneno de serpente e/ou insecto para a profilaxia e terapia de neoplasmas
ZA95908B (en) A synergistic formulation for treatment of rheumatic diseases
IL146962A0 (en) Aminotetralin derivatives for the therapy of cardiovascular diseases
IL126158A0 (en) Method for treating substance abuse
ZA96260B (en) A transdermal therapeutic system for the administration of (s)-3-methyl-5-(1-methyl-2-pyrrolidenyl)-isoxazole or one of its pharmaceutically acceptable salts
EP0872239A3 (en) Use of olanzapine for the manufacture of a medicament for the treatment of cerebral focal ischemia
CA2237643A1 (en) Therapeutic agent for acute hepatic failure

Legal Events

Date Code Title Description
0001 Granted